iTonic Holdings Ltd (ITOC)
ITOC trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F/A (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1970544/000121390026039356/0001213900-26-039356-index.htm. Net income: SEC 20-F/A (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ITOC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | China |
| IPO year | 2024 |
| SEC CIK | 0001970544 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $523K |
| Net income | -$5.1M |
| Operating income | -$5.2M |
| Net margin | -974.7% |
| Operating margin | -991.7% |
| Revenue growth | +16.7% |
| Cash | $1.5M |
| Total assets | $9.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 26.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt regarding the Company's ability to continue as a going concern." | 20-F 2026-03-30 |
| Cash and burn | $1.5M cash; operating cash flow -$808K a quarter. | Report 2025-12-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2025-12-31 |
| Reverse splits, 3 years | 1; latest 1-for-16 on 2026-10-06 | Source 2026-10-06 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-02-06 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | FORTUNE CPA, INC, Garden Grove, California, United States | PCAOB Form AP 2026-04-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $523K | -$5.1M | -$3.2M | $1.5M | No debt tags | $523K | 20-F/A 2026-04-02 |
| FY 2024 2024-12-31 | $448K | -$661K | -$775K | $6.2M | No debt tags | $448K | 20-F/A 2026-04-02 |
| FY 2023 2023-12-31 | $629K | -$241K | -$64K | $218K | No debt tags | $629K | 20-F/A 2026-04-02 |
| FY 2022 2022-12-31 | $680K | $84K | -$116K | $72K | No debt tags | $680K | 20-F 2025-03-20 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-3 | 2026-02-06 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-03-30 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-02 |
Source: SEC EDGAR submissions feed, 84 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +15.1% |
| 1 month | -49.7% |
| 3 months | -57.5% |
| Year to date | -70.6% |
| 1 year | -79.8% |
| From 52-week high | -86.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IRIX | IRIDEX Corporation | $0.6878 | -0.32% | $12.1M |
| QTI | QT Imaging Holdings Inc. | $1.80 | -4.26% | $26.4M |
| NDRA | ENDRA Life Sciences Inc. | $4.42 | -1.78% | $6.6M |
| ECOR | electroCore Inc. | $4.84 | -7.81% | $44.7M |
| POCI | Precision Optics Corporation Inc. | $4.97 | -4.97% | $54.6M |
| OM | Outset Medical Inc. | $3.39 | -9.12% | $64.0M |
| HYPR | Hyperfine Inc. | $0.6101 | -3.05% | $64.8M |
| NRXS | Neuraxis Inc. | $4.80 | -11.44% | $68.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier